Defective mismatch repair and benefit from bevacizumab for colon cancer: findings from NSABP C-08. - Pogue-Geile K; Yothers G; Taniyama Y; Tanaka N; Gavin P; Colangelo L; Blackmon N; Lipchik C; Kim SR; Sharif S; Allegra C; Petrelli N; et al. (Journal of the National Cancer Institute, 2013)